plasma
blood
healthi
pig
raw
materi
use
produc
spraydri
porcin
plasma
sdpp
feed
ingredi
function
protein
bioactiv
compon
wide
use
pig
diet
due
benefici
effect
postwean
perform
surviv
coffey
cromwel
torrallardona
manufactur
process
sdpp
involv
sever
biosecur
featur
includ
collect
healthi
anim
commerci
abattoir
compet
author
inspect
pool
blood
contain
antibodi
neutral
capac
varieti
pathogen
spraydri
throughout
substanc
extend
storag
time
control
temperatur
et
al
et
al
howev
technolog
develop
addit
redund
safeti
featur
investig
follow
recommend
sever
intern
agenc
emea
ultraviolet
light
nm
wavelength
uvc
disrupt
cellular
transcript
replic
lead
death
bacteria
virus
mold
keyser
et
al
due
format
thyminethymin
dimer
thyminecytosin
dimer
dna
molecul
cytosineuracil
dimer
rna
molecul
jagger
uvc
extens
use
disinfect
water
hijnen
lin
et
al
surfac
sizer
balasubramaniam
food
product
guerrerobeltran
import
valid
individu
inactiv
step
includ
commerci
product
process
sdpp
swine
bioassay
includ
intraperiton
inject
test
materi
pig
repres
extrem
sensit
method
test
infect
christopherhen
et
al
swine
bioassay
import
monitor
pig
inject
test
materi
viremia
andor
seroconvers
may
indic
presenc
infect
viru
test
materi
procedur
consid
sensit
method
test
safeti
specif
product
porcin
plasma
sampedro
et
al
determin
genom
detect
pcr
analys
infect
object
present
studi
determin
uvc
irradi
liquid
commerci
collect
porcin
plasma
specif
design
uv
system
develop
larg
volum
opaqu
liquid
surepur
turbul
could
inactiv
infect
viru
measur
pig
bioassay
primari
aim
evalu
inactiv
porcin
circoviru
uncommon
commerci
collect
plasma
qrtpcr
posit
econom
import
viru
concern
global
swine
industri
furthermor
presenc
possibl
transmiss
potenti
contamin
agent
import
swine
industri
porcin
reproduct
respiratori
syndrom
viru
prrsv
transmiss
gastroenter
coronaviru
tgev
swine
influenza
viru
siv
porcin
parvoviru
ppv
porcin
epidem
diarrhea
viru
pedv
swine
rotaviru
rva
bovin
viral
diarrhea
viru
bvdv
border
diseas
viru
bdv
hepat
e
viru
hev
salmonella
enterica
evalu
criterion
plasma
select
base
presenc
genom
plasma
batch
present
greater
number
genom
copi
time
lower
antibodi
titer
select
ten
batch
liquid
porcin
plasma
collect
commerci
abattoir
batch
plasma
collect
plasma
pool
pig
frozen
prior
prescreen
test
genom
antibodi
test
batch
use
uvc
test
select
base
highest
number
dna
copi
measur
realtim
quantit
pcr
qrtpcr
use
test
kit
lsi
vetmaxtm
porcin
circoviru
type
quantif
thermo
fisher
scientif
massachusett
usa
lowest
level
antibodi
analyz
elisa
ingezim
circo
elisa
ingenasa
madrid
spain
among
prescreen
liquid
plasma
batch
prior
uvc
irradi
select
plasma
batch
l
batch
tabl
thaw
filter
elimin
potenti
cryoprecipit
uvc
reactor
design
manufactur
sure
pure
oper
ag
zug
switzerland
system
design
creat
turbul
flow
reynold
number
insur
deliveri
uvc
radiat
particl
opaqu
liquid
flow
rate
maintain
lh
uv
lamp
switch
min
stabl
flow
posit
control
l
jl
sampl
collect
steril
contain
uvc
lamp
switch
irradi
start
one
liter
treat
plasma
collect
steril
contain
jl
previous
describ
et
al
sampl
plasma
irradi
jl
jl
jl
uvc
ml
use
intraperiton
inject
pig
approxim
day
age
blood
sampl
select
pig
collect
farm
origin
verifi
neg
result
prrsv
antibodi
genom
addit
anim
low
antibodi
elisa
sp
valu
matern
origin
neg
qrtpcr
total
male
piglet
day
age
initi
averag
bodi
weight
kg
transport
alloc
institut
de
recerca
tecnologia
irta
experiment
farm
lleida
spain
individu
room
separ
anim
three
week
start
studi
experiment
farm
piglet
sampl
day
age
experiment
group
establish
piglet
proven
seroneg
elisa
prrsv
day
age
three
pig
unthrifti
period
exclud
studi
remain
pig
weigh
eartag
randomli
distribut
five
experiment
group
pig
per
group
match
weight
group
pig
neg
control
group
pig
treatment
group
pig
posit
control
group
group
anim
alloc
separ
box
also
differ
room
thu
air
space
share
group
box
surfac
area
pig
environment
condit
room
maintain
area
heat
lamp
sourc
includ
insid
box
illumin
consist
natur
light
ensur
cross
contamin
treatment
group
extern
contamin
occur
room
close
air
entri
regul
strict
biosafeti
protocol
caretak
implement
caregiv
train
wear
tyvek
dupont
delaw
usa
overal
overcoat
head
cover
glove
entranc
room
daili
anim
care
group
n
repres
neg
control
group
inject
ml
phosphat
buffer
salin
pb
solut
salin
solut
vitulia
ern
laboratori
barcelona
spain
group
n
pig
inject
ml
nativ
nonuvc
irradi
plasma
raw
nativ
liquid
plasma
group
n
anim
inject
ml
plasma
uvc
irradi
jl
group
n
pig
inject
ml
plasma
uvc
treat
jl
group
n
use
posit
control
group
inject
ml
dose
tcid
ml
productsinoculum
administr
intraperiton
rout
group
anim
procedur
approv
committe
ethic
welfar
protocol
approv
number
piglet
monitor
daili
clinic
sign
infect
studi
period
blood
sampl
collect
day
postinject
test
viremia
antibodi
seroconvers
prrsv
tgev
siv
ppv
rva
pedv
bvdv
bdv
hev
enterica
end
studi
anim
euthan
overdos
sodium
pentoth
euthasol
laboratorio
ecuphar
barcelona
spain
piglet
necropsi
sampl
lung
tonsil
lymph
node
bile
fece
collect
analysi
select
plasma
batch
test
presenc
genom
antibodi
indic
previous
also
analyz
presenc
pathogen
commerci
qpcr
qrtpcr
hoofddorp
netherland
antibodi
bvdv
bdv
evalu
seroneutr
test
follow
oie
protocol
wwwoieint
inocul
anim
monitor
develop
viremia
antibodi
pathogen
identifi
plasma
inoculum
tabl
serum
sampl
taken
dpi
analyz
presenc
antibodi
prrsv
tgev
siv
ppv
rva
pedv
hev
enterica
commerci
kit
mention
antibodi
found
serum
sampl
dpi
presenc
viru
determin
serum
sampl
dpi
qrtpcr
serum
sampl
dpi
test
prrsv
qrtpcr
serum
collect
dpi
fece
dpi
test
ppv
rva
bile
dpi
test
presenc
hev
rna
siv
analyz
qrtpcr
serum
lung
tissu
dpi
sampl
qrtpcr
techniqu
previous
cite
among
porcin
plasma
batch
test
tabl
one
highest
load
lowest
antibodi
valu
select
batch
contain
x
dna
copiesml
ct
ct
valu
prrsv
european
strain
number
rna
copi
provid
techniqu
also
elisa
sp
ratio
low
moder
high
prrsv
antibodi
furthermor
select
plasma
use
inoculum
antibodi
siv
rva
ppv
hev
enterica
presenc
low
amount
nucleic
acid
siv
ct
rva
ct
ppv
ct
hev
ct
detect
tabl
experiment
period
necropsi
clinic
sign
infect
observ
piglet
neg
control
group
group
remain
free
prrsv
show
absenc
seroconvers
virus
entir
studi
period
contrast
piglet
group
posit
control
group
inocul
becam
infect
tabl
presenc
antibodi
ab
genom
pcr
differ
infecti
agent
test
porcin
plasma
inoculum
differ
anim
group
plasma
inoculum
untreat
abattoir
collect
porcin
plasma
use
bioassay
group
neg
control
group
pig
inject
ip
salin
group
pig
inject
ip
untreat
abattoir
plasma
jl
group
pig
inject
ip
jl
uvc
treat
plasma
group
pig
inject
ip
jl
uvc
treat
plasma
group
posit
control
group
pig
inocul
ab
serum
antibodi
pcr
serum
genom
posit
result
neg
result
na
analyz
nn
number
pig
posit
antibodi
genom
respect
total
number
pig
treatment
fece
neg
fecal
result
bile
neg
bile
result
within
dpi
measur
qrtpcr
pig
alreadi
seroconvert
follow
sampl
dpi
piglet
group
inject
raw
nativ
plasma
subject
uvc
jl
found
prrsv
posit
qrtpcr
seroconvert
dpi
evid
infect
qrtpcr
elisa
detect
group
jl
uvc
piglet
three
piglet
group
seroconvert
ppv
dpi
without
evid
viral
excret
fece
dpi
one
piglet
also
seroconvert
rva
dpi
neg
qrtpcr
fece
dpi
sera
dpi
dpi
one
group
piglet
jl
seroconvert
hev
without
presenc
viru
bile
seroconvers
siv
observ
group
jl
piglet
piglet
group
inject
intraperiton
uvc
irradi
plasma
jl
jl
respect
becom
virem
pcr
rtpcr
prrsv
siv
ppv
rva
hev
seroconvert
time
dpi
period
swine
bioassay
use
demonstr
effect
uvc
reduc
viral
load
may
present
liquid
commerci
plasma
vivo
model
intraperiton
administr
select
administr
rout
avoid
possibl
inactiv
loss
viral
particl
due
hydrochlor
acid
digest
enzym
gastrointestin
tract
kasorndorkbua
et
al
intraperiton
rout
main
rout
absorpt
inocul
materi
mesenter
blood
vessel
drain
portal
vein
pass
liver
luka
et
al
consequ
certain
amount
inject
liquid
may
pass
directli
across
diaphragm
small
lacuna
thorac
lymph
abuhijleh
et
al
system
circul
techniqu
shown
sensit
model
detect
infect
pathogen
gerber
et
al
dee
et
al
sampedro
et
al
although
commerci
collect
liquid
porcin
plasma
select
presenc
genom
also
contain
antibodi
presenc
small
amount
nucleic
acid
differ
virus
prrsv
siv
rva
ppv
hev
consist
endem
pathogen
present
commerci
swine
popul
catalonia
spain
region
de
deu
et
al
et
al
piglet
group
inject
intraperiton
ml
untreat
liquid
porcin
plasma
jl
seroconvert
prrsv
lesser
percentag
ppv
rva
hev
case
ppv
piglet
seroconvert
viru
excret
ppv
found
fece
end
studi
detect
sera
experiment
period
similarli
one
piglet
seroconvert
rva
sera
fece
remain
pcr
neg
furthermor
one
piglet
seroconvert
hev
bile
remain
pcr
neg
low
seroconvers
rate
could
result
extrem
low
quantiti
viru
commerci
collect
porcin
plasma
howev
pig
group
inject
liquid
porcin
plasma
treat
uvc
jl
jl
respect
seroconvert
becom
pcr
posit
demonstr
viral
particl
present
commerci
collect
porcin
plasma
inactiv
interestingli
commerci
collect
porcin
plasma
contain
dna
copiesml
howev
piglet
inject
untreat
plasma
jl
becom
virem
seroconvert
indic
viru
particl
infect
absenc
infect
could
either
associ
presenc
neutral
antibodi
commerci
pool
plasma
inadequ
amount
intraperiton
inject
infect
anim
viru
present
raw
plasma
alreadi
inactiv
despit
posit
pcr
result
neutral
antibodi
natur
present
pool
plasma
report
inactiv
log
tcid
polo
et
al
observ
also
confirm
posit
pcr
test
impli
pathogen
infect
convers
group
pig
receiv
untreat
liquid
plasma
seroconvert
prrsv
present
initi
inoculum
ct
valu
siv
rna
detect
raw
plasma
qrtpcr
high
ct
number
sinc
piglet
seroconvert
viru
presenc
siv
found
analyz
sampl
sera
lung
qrtpcr
like
low
load
siv
present
inoculum
unabl
caus
seroconvers
low
load
siv
present
inoculum
like
result
contamin
abattoir
due
administr
rout
select
infect
anim
expect
siv
exclus
respiratori
pathogen
howev
amount
viru
inoculum
would
greater
seroconvers
level
immun
could
happen
current
data
consist
previous
publish
research
differ
envelop
nonenvelop
virus
interest
swine
industri
prv
prrsv
siv
ppv
pedv
swine
vesicular
diseas
viru
svdv
classic
swine
fever
viru
csfv
bovin
viral
diarrhea
viru
bvdv
senecaviru
sva
inocul
bovin
porcin
plasma
inactiv
uvc
treatment
surepur
turbul
use
present
studi
vitro
assay
viru
quantif
allow
determin
inactiv
capac
uv
system
differ
virus
test
confirm
step
abl
inactiv
log
abovement
virus
world
health
organ
guidelin
viral
inactiv
remov
procedur
intend
assur
viral
safeti
human
blood
plasma
product
establish
robust
inactiv
process
capabl
remov
inactiv
least
log
wide
rang
virus
previou
studi
uvc
irradi
liquid
plasma
abl
inact
log
differ
bacteria
virus
polo
et
al
et
al
et
al
present
studi
also
demonstr
lack
transmiss
viru
uv
irradi
minimum
jl
therefor
uvc
irradi
compli
definit
robust
inactiv
process
furthermor
uvc
mechan
inactiv
dna
rna
damag
differ
thermal
inactiv
provid
spraydri
step
overal
result
indic
liquid
commerci
plasma
without
safeti
treatment
administ
intraperiton
suscept
pig
infect
virus
initi
plasma
viru
genom
howev
uv
irradi
surepur
turbul
system
jl
enough
avoid
transmiss
test
virus
anim
irradi
jl
chosen
level
irradi
liquid
plasma
use
commerci
special
blood
plasma
produc
opaqu
liquid
limit
penetr
uvc
irradi
therefor
affect
effici
pathogen
inactiv
matak
et
al
groenewald
et
al
howev
suffici
turbul
introduc
liquid
materi
expos
surfac
uv
sourc
therefor
overcom
limit
penetr
uv
irradi
alberini
et
al
sure
pure
turbul
design
creat
turbul
flow
success
use
pasteur
opaqu
liquid
like
fruit
juic
wine
keyser
et
al
frederick
et
al
milk
donaghi
et
al
addit
case
anim
plasma
uv
dose
jl
demonstr
effect
function
protein
present
sdpp
polo
et
al
cottingim
et
al
summari
result
studi
demonstr
swine
bioassay
sensit
techniqu
abl
detect
infect
raw
liquid
plasma
confirm
infecti
prrsv
moreov
uvc
treatment
seem
use
step
inactiv
potenti
pathogen
contamin
commerci
collect
anim
plasma
subsequ
use
produc
spraydri
anim
plasma
e
et
al
veterinari
microbiolog
